Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03520868 · ClinicalTrials.gov registry record
Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs
A clinical trial, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- 60
- Enrollment target
NCT03520868 is a clinical trial that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 60 participants.
The verdict
NCT03520868 has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
To observe, using a prospectively designed study, the effect of type of oral anticoagulant on intra-procedural heparin requirements in patients undergoing Atrial Fibrillation ablation and to assess whether ACT assay accurately reflects heparin anti coagulation effect.
Interventions
- DIAGNOSTIC_TEST Monitoring Anti Factor Xa level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-05-05 |
| Est. Completion | 2020-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03520868
The ClinicalTrials.gov registry entry for NCT03520868 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Monitoring Anti Factor Xa level is the first listed.
NCT03520868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03520868 about?
NCT03520868 is a clinical study titled "Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs". To observe, using a prospectively designed study, the effect of type of oral anticoagulant on intra-procedural heparin requirements in patients undergoing Atrial Fibrillation ablation and to assess whether ACT assay accurately reflects heparin anti coagulation effect.
What is the current status of trial NCT03520868?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-05-05. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03520868?
The interventions under investigation include: Monitoring Anti Factor Xa level (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03520868?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.